In a complex regulatory environment, post-market surveillance is a continuous process that demands precision, adaptability ...

Gilead licences Sprint Bioscience’s pre-clinical TREX1 inhibitor programme, gaining a novel immuno-oncology asset targeting ...

ATHENS, GEORGIA / ACCESS Newswire / November 26, 2025 / In response to the devastating outbreak of Equine Herpesvirus-1 (EHV-1) linked to the WPRA event in Waco, Texas, Good Salt Life, Inc., a wholly ...

Company plans to distribute Dream Bowl 2026 Meme Coin to shareholders as of a to-be-determined December 2025 date with distribution expected in January 2026 TAMPA, FLORIDA / ACCESS Newswire / November ...

Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance marketsCommercial integration expands MaxYield™ and CardioYield™ ...

Bristol and London, UK, 26 November 2025 - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Royal Free London NHS Foundation Trust, through its Cell ...

"We built real medicine while the industry chased loopholes," said Duane Boise, President and CEO of MMJ International ...

The Food for the Brain Foundation’s Cognitive Function Test will now be used to assess blood biomarkers being developed in the ‘READ OUT’ trial, a UK-based research project. The project, headed by ...

Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will present at the ...

Queen Square Imaging Centre – the world-leading centre treating patients with Essential Tremor and Parkinson's - has launched a brand-new podcast to support patients called Queen Square in ...

Modus Therapeutics Holding AB (“Modus Therapeutics”) hereby publishes an interim report for the third quarter of 2025. The report is available on the company’s website ( and as an attachment to this ...